Mark Lambie is a senior lecturer in renal medicine at Keele University and honorary renal consultant at the University Hospitals of North Midlands.
His PhD focussed on the use of epidemiological techniques to study the role of inflammation in PD and current projects include the development of a competing risks prognostic model for EPS and death as part of the PD-CRAFT study.
He is part of the UK P-DOPPS team and co-chair of the UK PD Clinical Study Group.